RxDoctor Payments Data

Leah Carlson

Family · West Memphis, ARNPI 1942977301

Payments from drug & device makers

$561in general payments, 2019–2025

Across 33 payments — averaging $17.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$135
  • Novo Nordisk$93
  • Amgen$60
  • Kowa Pharmaceuticals America, Inc.$60
  • AstraZeneca$57
  • Exeltis, USA Inc.$33
  • plus $125 from 6 others

What the payments were for

  • Food & beverage$561100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$561 in reported general payments places this provider in the 55th percentile of 2,103 family providers in Arkansas.

See all family providers in Arkansas

Medicare billing

Part B allowed, 2024
$30,201
Medicare patients
187
Services billed
6,762

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide26$31,369
Trelegy ElliptaFluticasone/Umeclidin/Vilanter41$29,527
JardianceEmpagliflozin18$11,134
OzempicSemaglutide11$10,458
EliquisApixaban12$9,667
FarxigaDapagliflozin Propanediol12$7,998
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen197$2,694
Albuterol Sulfate HfaAlbuterol Sulfate80$2,517
Potassium Chloride81$1,360
ValacyclovirValacyclovir Hcl16$1,339
Cefdinir73$1,335
Celecoxib14$1,291
Diclofenac Sodium65$1,179
Omeprazole95$1,089
Ventolin HfaAlbuterol Sulfate14$1,010

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$31$31,36926 claims
GSKTrelegy Ellipta$16$29,52741 claims
Novo NordiskOzempic$93$10,45811 claims
PfizerEliquis$17$9,66712 claims
AstraZenecaFarxiga$57$7,99812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,103 family providers in Arkansas.

Other family in West Memphis

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →